Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrel

This publication has 8 references indexed in Scilit:

• Latin American experience with two low–dose oral contraceptives containing 30 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel
  Contraception, 2000
• Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study
  Contraception, 1999
• Large observational trial of a new low-dose oral contraceptive containing 20 μg ethinylestradiol and 100 μg levonorgestrel (Miranova^r`) in Germany
  The European Journal of Contraception & Reproductive Health Care, 1999
• A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cycles
  Contraception, 1997
• Shorter pill-free interval in combined oral contraceptives decreases follicular development
  Contraception, 1996
• The effect of desogestrel, gestodene, and other factors on spotting and bleeding
  Contraception, 1996
• A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene
  Gynecological Endocrinology, 1996
• Oral contraceptives and cycle control: A critical review of the literature
  Advances in Contraception, 1992